IPO Premiums
IPO calendar
SASHRIAHIMSAListed

Shri Ahimsa Naturals Limited

Book Built Issue IPO · NSE

Price band
₹113 - ₹119
Lot size
1,200 shares
Issue amount
₹73.81 cr
Total subscription
62.71×
Current price₹462.15
Listing price ₹140
Watch live price ↗
Opens
25 Mar 2025
Closes
27 Mar 2025
Allotment
28 Mar 2025
Listing
2 Apr 2025

Offer at a glance

Issue overview

Issue size
62,02,800 shares
Face value
₹10 per share
Minimum investment
₹1,35,600
Fresh issue
₹50.02 cr
Offer for sale
₹23.79 cr
Registrar
Cameo Corporate Services Limited
Listing exchange
NSE
Maximum investment
₹1,42,800
Issue type
Book Built Issue IPO
Shares before issue
1,91,26,500
Shares after issue
2,33,30,100

Lot sizes

CategoryLotsSharesAmount
RETAIL11,200₹1,42,800
HNI22,400₹2,85,600

Share reservation

RETAIL33.57%
NII (HNI)14.26%
Anchor28.28%
QIB18.86%
Market Maker5.03%

Subscription & GMP

Subscription by category

Total subscribed62.71×

Missing multiples are calculated from bids and offered shares when available.

QIB21.23×
NIB182.82×
RETAIL35×

GMP history

0112220 Mar: ₹021 Mar: ₹322 Mar: ₹1025 Mar: ₹1226 Mar: ₹1227 Mar: ₹2228 Mar: ₹1829 Mar: ₹1231 Mar: ₹151 Apr: ₹19.512 Nov: ₹19.520 May: ₹19.5
20 Mar₹19.520 May

Application-wise demand

CategoryReserved applicationsApplied applications
QIB—35
NIB—5,465
RETAIL—60,723

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs13.92295.58
RETAIL24.78866.98

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
050100150Mar-22 · Revenue: 59Mar-22 · Profit after tax: 11Mar-22Mar-23 · Revenue: 106Mar-23 · Profit after tax: 38Mar-23Mar-24 · Revenue: 79Mar-24 · Profit after tax: 19Mar-24Sep-24 · Revenue: 41Sep-24 · Profit after tax: 10Sep-24
RevenueProfit after tax

Key performance indicators

MetricSep-24Mar-24Mar-23
EPS5.2510.1920.85
ROE9.7822.2558.58
ROCE12.5925.6972.46
RONW9.7822.2558.58
PRE IPO(PE)012.190
POST IPO(PE)14.2500

Values and labels as reported in the issue data.

Company information

Company profile

Shri Ahimsa Naturals Limited has been around since 1990, specializing in extracting and producing Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine. They also trade in other herbal extracts. Their products are widely used in industries like food & beverages, nutraceuticals, cosmetics, and pharmaceuticals, thanks to their various health benefits. The company offers Natural Caffeine, sourced from coffee and tea seeds, which is commonly found in energy drinks, soft drinks, cosmetics, and medicines. They also produce Green Coffee Bean Extract, made from unroasted coffee seeds, known for its antioxidant properties and potential weight management benefits. Shri Ahimsa Naturals exports to several countries, including the USA, Germany, South Korea, the UK, and Thailand. For the period ending September 30, 2024, they reported export revenues of ₹3,530.91 lakhs. In previous years, exports reached ₹7,463.71 lakhs in Fiscal 2023, ₹5,633.50 lakhs in Fiscal 2022, and ₹9,988.01 lakhs in their highest fiscal year. Their manufacturing facility in Jaipur, Rajasthan, follows top global standards like ISO 9001:2015, ISO 22000:2018, ISO 45001:2018, ISO 14001:2015, HACCP, and GMP, ensuring high-quality production. As of March 2025, the company had around 80 employees.

Strengths

  • Expert Leadership – Guided by seasoned professionals, fostering growth and innovation.
  • Cutting-Edge Manufacturing & R&D – Modern facility in Jaipur, delivering high-quality products.
  • Trusted Global Partnerships – Long-standing relationships across food & beverage, nutraceuticals, cosmetics, and pharmaceuticals.

Risk factors

  • Project Execution Challenges – The ₹3,500 lakh investment in Shri Ahimsa Healthcare Private Limited’s new manufacturing unit may face delays, budget overruns, and regulatory dependencies, potentially impacting operations and financial stability.
  • Audit Observations – Statutory Auditors have highlighted certain qualifications in audit reports for the half-year ending September 30, 2024, and fiscal years 2024, 2023, and 2022, which could raise concerns about financial compliance and transparency.
  • Supply Chain & Vendor Risks – Delays in acquiring machinery, equipment, or completing construction work for the new unit could hinder expansion, increase costs, and affect overall operations.

Promoters

Mr Nemi Chand Jain

Mrs Sumitra Jain

Mr Amit Kumar Jain

Mr Sumit Jain

Mrs Prerna Jain

M/s Ahimsa Holdings Private Limited

M/s Bimneer Investments Private Limited.

Registrar & documents

Lead manager

Srujan Alpha Capital Advisors LLP

Registered office

E-94, RIICO Industrial Area Bagru, Ext. Bagru

0141-2202482

[email protected]Company website ↗

Understanding SHRIAHIMSA IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.